Hong Kong Stock Connect healthcare and medical stocks surge sharply at low levels! Both jump over 3%

On March 24th, Hong Kong stocks rebounded across the board, with the pharmaceutical and healthcare sectors leading the rally. The 100% innovative drug development target—Hong Kong Stock Connect Innovation Drug ETF (520880) and the Hong Kong Stock Connect Healthcare ETF with high CXO content, Huabao (159137)—both opened high and briefly rose over 3% during the trading session. Yesterday, both ETFs hit new all-time closing lows.

On the news front, last night, WuXi AppTec listed companies disclosed their 2025 performance. In 2025, WuXi Helian achieved revenue of 5.944 billion yuan, up 46.7% year-on-year, with overseas revenue increasing to 85%; adjusted net profit reached 1.559 billion yuan, up 69.9%. The total value of unfulfilled orders rose to $1.49 billion, up 50.3%. WuXi KANGDE achieved revenue of 45.456 billion yuan, up 15.84%, and net profit attributable to shareholders was approximately 19.151 billion yuan, up 102.65%. The company expects overall revenue for 2026 to reach between 51.3 billion and 53 billion yuan, with ongoing business revenue growing 18%-22% year-on-year.

CXO industry leaders continue to show high growth, strongly confirming the industry’s fundamental recovery trend. In the secondary market, Hong Kong pharmaceutical stocks have been adjusting since September last year and are now at a stage low, making the leading stocks more attractive in terms of value.

There are opportunities for a rebound in Hong Kong pharmaceutical stocks at low levels. Focus on two key tools: Huabao (159137), the Hong Kong Stock Connect Healthcare ETF, with about 70% of positions allocated to CXO + AI healthcare, covering innovative drugs and medical devices (including brain-machine interfaces). Its top ten holdings include rare internet healthcare giants like JD Health and Alibaba Health. The Hong Kong Stock Connect Innovation Drug ETF (520880), with 100% of its holdings in innovative drug R&D companies, has over 70% of its top ten holdings, highlighting its leading industry attributes.

Daily Economic News

(Edited by: Zhang Xiaobo)

【Disclaimer】This article reflects only the author’s personal views and is not related to Hexun. Hexun.com maintains neutrality regarding the statements and opinions expressed in this article and does not provide any explicit or implicit guarantees regarding the accuracy, reliability, or completeness of the content. Readers should use this for reference only and bear all responsibilities themselves. Email: news_center@staff.hexun.com